C-reactive protein in arrhythmogenic right ventricular dysplasia/ cardiomyopathy and relationship with ventricular tachycardia

Cardiology Research and Practice

Volumn 1, Issue 1, 2010, Pages

  Bonny, Aimé ^a   Lellouche, Nicolas ^b   Ditah, Ivo ^c   Hidden Lucet, Franoise ^d   Yitemben, Martial T ^e   Granger, Benjamin ^d   Larrazet, Fabrice ^a   Frank, Robert ^d   Fontaine, Guy ^d  

^a Hopital Saint Camille   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e Centre Hospitalier le Cateau   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART RIGHT VENTRICLE DYSPLASIA; HEART RIGHT VENTRICLE OUTFLOW TRACT; HEART VENTRICLE TACHYCARDIA; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

EID: 79959472519     PISSN: None     EISSN: 20900597     Source Type: Journal    
DOI: 10.4061/2010/919783     Document Type: Article

References (33)

1. Frank R., Fontaine G., Vedel J., Electrocardiologie de quatre cas de dysplasie ventriculaire droite arythmogene Arch Mal Cur Vaiss 1978 71 963 972
2. Marcus F. I., Fontaine G. H., Guiraudon G., Right ventricular dysplasia: a report of 24 adult cases Circulation 1982 65 2 384 399
3. Thiene G., Nava A., Corrado D., Rossi L., Pennelli N., Right ventricular cardiomyopathy and sudden death in young people The New England Journal of Medicine 1988 318 3 129 133 (Pubitemid 18035134)
4. Chimenti C., Pieroni M., Maseri A., Frustaci A., Histologic findings in patients with clinical and instrumental diagnosis of sporadic arrhythmogenic right ventricular dysplasia Journal of the American College of Cardiology 2004 43 12 2305 2313 (Pubitemid 38757603)
5. Corrado D., Fontaine G., Marcus F. I., McKenna W. J., Nava A., Thiene G., Wichter T., Arrhythmogenic right ventricular dysplasia/cardiomyopathy: need for an international registry Circulation 2000 101 11 e101 e106
6. Wolpert C., Echternach C., Veltmann C., How to differentiate right ventricular outflow tract tachycardia from arrhythmogenic right ventricular cardiomyopathy? Cardiac Arrhythmias 2005 345 349
7. Vereckei A., Duray G., Sznsi G., Altemose G. T., Miller J. M., Application of a new algorithm in the differential diagnosis of wide QRS complex tachycardia European Heart Journal 2007 28 5 589 600 (Pubitemid 47355500)
8. Pai J. K., Pischon T., Ma J., Manson J. E., Hankinson S. E., Joshipura K., Curhan G. C., Rifai N., Cannuscio C. C., Stampfer M. J., Rimm E. B., Inflammatory markers and the risk of coronary heart disease in men and women The New England Journal of Medicine 2004 351 25 2599 2610 (Pubitemid 39628581)
9. Ridker P. M., Hennekens C. H., Buring J. E., Rifai N., C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women The New England Journal of Medicine 2000 342 12 836 843 (Pubitemid 30165206)
10. Pearson T. A., Blair S. N., Daniels S. R., Eckel R. H., Fair J. M., Fortmann S. P., Franklin B. A., Goldstein L. B., Greenland P., Grundy S. M., Hong Y., Miller N. H., Lauer R. M., Ockene I. S., Sacco R. L., Sallis J. F. Jr., Smith S. C. Jr., Stone N. J., Taubert K. A., AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases Circulation 2002 106 3 388 391 (Pubitemid 34778969)
11. Ridker P. M., Danielson E., Fonseca F. A. H., Genest J., Gotto Jr. A. M., Kastelein J. J.P., Koenig W., Libby P., Lorenzatti A. J., MacFadyen J. G., Nordestgaard B. G., Shepherd J., Willerson J. T., Glynn R. J., Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein The New England Journal of Medicine 2008 359 21 2195 2207
12. Henningsen K. M. A., Therkelsen S. K., Bruunsgaard H., Krabbe K. S., Pedersen B. K., Svendsen J. H., Prognostic impact of hs-CRP and IL-6 in patients with persistent atrial fibrillation treated with electrical cardioversion Scandinavian Journal of Clinical and Laboratory Investigation 2009 69 3 425 432
13. Dai S., Zhang S., Guo Y. H., Chu J., Hua W., Fang Z. W., C-reactive protein and atrial fibrillation in idiopathic dilated cardiomyopathy Clinical Cardiology 2009 32 9 E45 E50
14. Streitner F., Kuschyk J., Veltmann C., Ratay D., Schoene N., Streitner I., Brueckmann M., Schumacher B., Borggrefe M., Wolpert C., Role of proinflammatory markers and NT-proBNP in patients with an implantable cardioverter-defibrillator and an electrical storm Cytokine 2009 47 3 166 172
15. Kaneko H., Anzai T., Naito K., Kohno T., Maekawa Y., Takahashi T., Kawamura A., Yoshikawa T., Ogawa S., Role of ischemic preconditioning and inflammatory response in the development of malignant ventricular arrhythmias after reperfused ST-elevation myocardial infarction Journal of Cardiac Failure 2009 15 9 775 781
16. Anker S. D., Coats A. J. S., How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH International Journal of Cardiology 2002 86 2-3 123 130 (Pubitemid 35284800)
17. Bozkurt B., Torre-Amione G., Warren M. S., Whitmore J., Soran O. Z., Feldman A. M., Mann D. L., Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure Circulation 2001 103 8 1044 1047 (Pubitemid 32200174)
18. Chung E. S., Packer M., Lo K. H., Fasanmade A. A., Willerson J. T., Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-, in patients with moderate-to-severe heart failure: results of the anti-TNF therapy against congestive heart failure (ATTACH) trial Circulation 2003 107 25 3133 3140 (Pubitemid 36793081)
19. Kaneko H., Anzai T., Naito K., Kohno T., Maekawa Y., Takahashi T., Kawamura A., Yoshikawa T., Ogawa S., Role of ischemic preconditioning and inflammatory response in the development of malignant ventricular arrhythmias after reperfused ST-elevation myocardial infarction Journal of Cardiac Failure 2009 15 9 775 781
20. Charles-Schoeman C., Khanna D., Furst D. E., McMahon M., Reddy S. T., Fogelman A. M., Paulus H. E., Park G. S., Gong T., Ansell B. J., Effects of high-dose atorvastatin on antiinflammatory properties of high density lipoprotein in patients with rheumatoid arthritis: a pilot study Journal of Rheumatology 2007 34 7 1459 1464 (Pubitemid 47067979)
21. Chiu J. H., Abdelhadi R. H., Chung M. K., Gurm H. S., Marrouche N. F., Saliba W. I., Natale A., Martin D. O., Effect of statin therapy on risk of ventricular arrhythmia among patients with coronary artery disease and an implantable cardioverter-defibrillator American Journal of Cardiology 2005 95 4 490 491 (Pubitemid 40247545)
22. De Sutter J., Tavernier R., De Buyzere M., Jordaens L., De Backer G., Lipid lowering drugs and recurrences of life-threatening ventricular arrhythmias in high-risk patients Journal of the American College of Cardiology 2000 36 3 766 772
23. Mitchell L. B., Powell J. L., Gillis A. M., Kehl V., Hallstrom A. P., Are lipid-lowering drugs also antiarrhythmic drugs? An analysis of the antiarrhythmics versus implantable defibrillators (AVID) trial Journal of the American College of Cardiology 2003 42 1 81 87 (Pubitemid 36760765)
24. Vyas A. K., Guo H., Moss A. J., Olshansky B., McNitt S. A., Hall W. J., Zareba W., Steinberg J. S., Fischer A., Ruskin J., Andrews M. L., Reduction in ventricular tachyarrhythmias with statins in the multicenter automatic defibrillator implantation trial (MADIT)-II Journal of the American College of Cardiology 2006 47 4 769 773 (Pubitemid 43243099)
25. Konstantino Y., Kusniec J., Reshef T., David-Zadeh O., Mazur A., Strasberg B., Battler A., Haim M., Inflammatory biomarkers are not predictive of intermediate-term risk of ventricular tachyarrhythmias in stable CHF patients Clinical Cardiology 2007 30 8 408 413 (Pubitemid 47312892)
26. Corrado D., Basso C., Thiene G., Arrhythmogenic right ventricular cardiomyopathy: diagnosis, prognosis, and treatment Heart 2000 83 5 588 595 (Pubitemid 30316741)
27. Cooper L. T. Jr., Myocarditis The New England Journal of Medicine 2009 360 15 1526 1538
28. Hofmann R., Trappe H.-J., Klein H., Kemnitz J., Chronic (or healed) myocarditis mimicking arrhythmogenic right ventricular dysplasia European Heart Journal 1993 14 5 717 720 (Pubitemid 23170691)
29. Thiene G., Corrado D., Nava A., Rossi L., Poletti A., Boffa G. M., Daliento L., Pennelli N., Right ventricular cardiomyopathy: is there evidence of an inflammatory aetiology? European Heart Journal 1991 12 22 25
30. Magnani J. W., Dec G. W., Myocarditis: current trends in diagnosis and treatment Circulation 2006 113 6 876 890
31. Valente M., Calabrese F., Thiene G., Angelini A., Basso C., Nava A., Rossi L., In vivo evidence of apoptosis in arrhythmogenic right ventricular cardiomyopathy American Journal of Pathology 1998 152 2 479 484 (Pubitemid 28106394)
32. Basso C., Thiene G., Corrado D., Angelini A., Nava A., Valente M., Arrhythmogenic right ventricular cardiomyopathy: dysplasia, dystrophy, or myocarditis? Circulation 1996 94 5 983 991 (Pubitemid 26292851)
33. Sen-Chowdhry S., Morgan R. D., Chambers J. C., McKenna W. J., Arrhythmogenic cardiomyopathy: etiology, diagnosis, and treatment Annual Review of Medicine 2010 61 233 253